Feinstein Institutes Develop New Drug To Help Diagnose Parkinson's Disease
December 24, 2019
December 24, 2019
MANHASSET, New York, Dec. 24 -- Feinstein Institute for Medical Research issued the following news release:
* * *
- Dr. Thomas Chaly pushes for approval of imaging agent to combat Parkinson's
* * *
The Feinstein Institutes for Medical Research has received US Food and Drug Administration (FDA) approval for a new Positron Emission Tomography (PET) drug to combat Parkinson's disease. Fluorodopa F 18 Injection (NDA 200655) will help visualize dopa . . .
* * *
- Dr. Thomas Chaly pushes for approval of imaging agent to combat Parkinson's
* * *
The Feinstein Institutes for Medical Research has received US Food and Drug Administration (FDA) approval for a new Positron Emission Tomography (PET) drug to combat Parkinson's disease. Fluorodopa F 18 Injection (NDA 200655) will help visualize dopa . . .